Inactive Instrument

News Sangui Biotech International, Inc. Other OTC

Equities

SGBI

US80105B1017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Sangui BioTech International Inc.: Significant increase in sales in the first three quarters of the year - Further reduction of the operating loss	23-05-15	EQ
Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-12	CI
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year - Further reduction of the operating loss	23-02-13	EQ
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-07	AQ
Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-07	CI
Sangui BioTech International Inc.: - Sales of USD 41,029 in first quarter - For the first time, positive quarterly result in the company's history	22-11-11	EQ
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-10	AQ
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-10	CI
SANGUI BIOTECH INTERNATIONAL INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-11-03	AQ
Sangui BioTech International Inc.: Increase in sales in the first quarter of 121% - Highest quarterly sales in the company's history	22-10-12	EQ
Sangui BioTech International Inc.: Sales of USD 69,190 in fiscal year 2022 - Reduction of the operating loss	22-09-29	EQ
SANGUI BIOTECH INTERNATIONAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-09-28	AQ
Sangui Biotech International, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-28	CI
Sangui Biotech International, Inc. Auditor Raises 'Going Concern' Doubt	22-09-27	CI
Sangui BioTech International Inc.: - Increase in sales in the first nine months of the year - Further reduction of the operating loss	22-05-17	EQ
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-16	AQ
Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-16	CI
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year - Further reduction of the operating loss	22-02-16	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sangui Biotech International, Inc. Other OTC

Equities

SGBI

US80105B1017

Summary

Filters